IRIS
VINCENZI, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 15.695
NA - Nord America 2.784
EU - Europa 1.610
SA - Sud America 55
OC - Oceania 51
AF - Africa 42
AN - Antartide 1
Totale 20.238
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 12.817
US - Stati Uniti d'America 2.676
HK - Hong Kong 1.559
CN - Cina 1.060
GB - Regno Unito 545
IT - Italia 429
DE - Germania 200
NL - Olanda 109
IN - India 107
CA - Canada 87
FI - Finlandia 62
UA - Ucraina 49
AU - Australia 48
JP - Giappone 43
TR - Turchia 39
ZA - Sudafrica 33
BR - Brasile 32
FR - Francia 28
EE - Estonia 23
CZ - Repubblica Ceca 22
PL - Polonia 21
ES - Italia 20
MX - Messico 19
CH - Svizzera 16
BE - Belgio 15
ID - Indonesia 15
AT - Austria 12
SE - Svezia 12
KR - Corea 10
RU - Federazione Russa 9
SA - Arabia Saudita 8
PE - Perù 7
TW - Taiwan 7
AR - Argentina 6
CL - Cile 6
LT - Lituania 5
UZ - Uzbekistan 5
PT - Portogallo 4
RO - Romania 4
EG - Egitto 3
IE - Irlanda 3
IL - Israele 3
IR - Iran 3
PH - Filippine 3
SI - Slovenia 3
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
FK - Isole Falkland (Malvinas) 2
GH - Ghana 2
GR - Grecia 2
HU - Ungheria 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AQ - Antartide 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
CY - Cipro 1
HR - Croazia 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
LV - Lettonia 1
MS - Montserrat 1
NG - Nigeria 1
NO - Norvegia 1
PS - Palestinian Territory 1
SL - Sierra Leone 1
SN - Senegal 1
TH - Thailandia 1
TV - Tuvalu 1
YE - Yemen 1
Totale 20.238
Salva come PNG Salva come JPEG
Città #
Hong Kong 1.532
Singapore 1.019
Ashburn 703
Boardman 656
Hefei 550
London 498
Shanghai 351
San Francisco 105
Los Angeles 103
Rome 81
Munich 80
Pune 77
Amsterdam 74
Toronto 64
Council Bluffs 62
Seattle 62
Washington 54
Santa Clara 40
Turku 37
New York 29
Milan 27
Helsinki 25
Tokyo 24
Melbourne 23
Warsaw 21
Brno 20
São Paulo 20
St Louis 17
Chicago 16
Johannesburg 15
Boston 14
Secaucus 14
The Dalles 14
Brooklyn 13
Sydney 13
Canberra 12
Central 12
Hasselt 12
Mexico City 12
Naples 12
West Jordan 12
Charlotte 10
Chennai 9
Hanover 9
Montreal 9
Stockholm 9
Bologna 8
Modena 8
Sona 8
Vienna 8
Frankfurt am Main 7
Haikou 7
Turin 7
Ankara 6
Campobasso 6
Dallas 6
Guangzhou 6
Lima 6
Mong Kok 6
Padova 6
Palermo 6
Redmond 6
Riyadh 6
Bari 5
Beijing 5
Ekimaedori 5
Hangzhou 5
Mumbai 5
New Taipei 5
Novara 5
Paris 5
San Pietro in Lama 5
Teramo 5
Yeonsu-gu 5
Andover 4
Cascina 4
Casole d'Elsa 4
Charleston 4
Gennevilliers 4
Istanbul 4
Las Vegas 4
Liverpool 4
Manchester 4
Mantova 4
Marcellina 4
Markham 4
Miami 4
Monza 4
Nagoya 4
Nanjing 4
New Delhi 4
Parma 4
Shijiazhuang 4
Willisau 4
Wuhan 4
Atlanta 3
Aversa 3
Baoding 3
Barcelona 3
Berlin 3
Totale 6.838
Salva come PNG Salva come JPEG
Nome #
Aspetti etico-clinici del percorso decisionale ed assistenziale per la sedazione palliativa 284
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 216
Cardiotossicità da antracicline 207
A novel predictive biomarker of immunotherapy response in metastatic renal cell carcinoma (mRCC): The lymphocyte microRNA expression profile. 206
Doctor-patient communication tricks. Ontological study a Campus Bio-Medico University of Rome 202
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 199
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 199
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 198
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 193
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 193
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 190
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 190
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 188
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 188
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 188
Premetastatic niche: ready for new therapeutic interventions? 187
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 183
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 182
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 182
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 181
Activity of chemotherapy in inflammatory myofibroblastic tumor (IMT): A retrospective analysis within the Italian Rare Tumours Network (RTR). 180
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma 179
Sarcopenia Does Not Impact the Outcome of Patients with Multiple Myeloma Consolidated with Autologous Hematopoietic Stem Cell Transplantation 178
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 177
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 177
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 177
Urinary complications from breast cancer metastasis: case report and review of the literature 177
Prevention of radiotherapy-induced emesis 177
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 175
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 175
Survey on learning needs and preferred sources of information to meet these needs in Italian oncology patients receiving chemotherapy 175
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma 173
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 172
Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma 171
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 168
CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients 167
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 166
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 164
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 162
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 162
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 161
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 158
Docetaxel induced pericardial effusion 158
A staphylococcus aureus coinfection on a COVID-19 pneumonia in a breast cancer patient 154
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 148
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 134
Liver harvesting surgical technique for the treatment of retro-hepatic caval thrombosis concomitant to renal cell carcinoma: perioperative and long-term results in 15 patients without mortality 119
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 104
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 103
A giant sarcoma of the parotid gland: A case report and review of the literature 102
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 100
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 98
An international survey on the use of guidelines for palliative sedation therapy 97
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 96
Circulating endothelial cell (CEC) kinetic in patients with Multiple Myeloma (MM) who receive Au-HSCT (Autologous Hematopoietic Stem Cell Transplantation) 93
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 92
'Old' and 'new' drugs for the treatment of cancer pain 92
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 91
Adenogenesis Factors FGF7, FGF10, FGF23, IFN-τ and HGF in Endometriosis Tissue Respect to Eutopic Endometrium: An Immunohistochemical Study 90
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 90
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 86
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 86
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 86
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 86
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 86
Locally recurrent extraskeletal myxoid chondrosarcoma of the shoulder: a case of complete neoadjuvant radiotherapy response 85
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 85
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 85
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 85
Activity of sirolimus in advanced epithelioid hemangioendothelioma (EHE): A retrospective analysis within the Italian Rare Tumor Network (RTR). 85
Biological effects of cabozantinib on bone microenvironment 85
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 85
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 84
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 83
Idiosyncratic reaction after oxaliplatin infusion 83
Infusion of bevacizumab increases the risk of intestinal perforation: results on a series of 143 patients consecutively treated 83
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 82
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 82
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 82
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 82
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 82
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 81
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 81
Atypical chronic head and neck pain: don't forget Eagle's syndrome 81
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 80
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 80
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 80
Azygo-tracheal fistula in a complete implantable central venous system 78
Cardiotoxicity of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Pathophysiology, Clinical Implications, and Echocardiographic Assessment 76
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 76
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 74
Persisting perianal ulcer after radiotherapy for anal cancer: recurrence of disease or late radiation-related complication? 74
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl) 73
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 71
Fatal thrombocytopenia and thrombocytopathia: An unusual onset of non small cell lung cancer 71
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 68
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients 63
Pamidronate induces modifications of circulating angiogenetic factors in cancer patients 60
Classic Kaposi Sarcoma: to treat or not to treat? 58
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 58
Totale 12.839
Salva come PNG Salva come JPEG
Categoria #
all - tutte 187.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 187.333
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022754 0 9 12 4 49 12 10 9 24 23 26 576
2022/2023194 23 7 3 14 7 8 19 15 15 7 69 7
2023/20241.890 49 213 155 165 158 766 27 113 27 53 81 83
2024/202517.411 277 217 720 138 146 421 296 76 1.523 1.325 5.825 6.447
2025/2026161 161 0 0 0 0 0 0 0 0 0 0 0
Totale 20.410